IL106751A0 - Pharmaceutical compositions for the treatment of reversible obstructive airways diseases - Google Patents

Pharmaceutical compositions for the treatment of reversible obstructive airways diseases

Info

Publication number
IL106751A0
IL106751A0 IL106751A IL10675193A IL106751A0 IL 106751 A0 IL106751 A0 IL 106751A0 IL 106751 A IL106751 A IL 106751A IL 10675193 A IL10675193 A IL 10675193A IL 106751 A0 IL106751 A0 IL 106751A0
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical compositions
obstructive airways
airways diseases
reversible obstructive
Prior art date
Application number
IL106751A
Other languages
English (en)
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of IL106751A0 publication Critical patent/IL106751A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL106751A 1992-08-25 1993-08-20 Pharmaceutical compositions for the treatment of reversible obstructive airways diseases IL106751A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929218027A GB9218027D0 (en) 1992-08-25 1992-08-25 Novel method of treatment

Publications (1)

Publication Number Publication Date
IL106751A0 true IL106751A0 (en) 1993-12-08

Family

ID=10720906

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106751A IL106751A0 (en) 1992-08-25 1993-08-20 Pharmaceutical compositions for the treatment of reversible obstructive airways diseases

Country Status (6)

Country Link
AU (1) AU4967193A (fr)
GB (1) GB9218027D0 (fr)
IL (1) IL106751A0 (fr)
MX (1) MX9305152A (fr)
WO (1) WO1994004148A1 (fr)
ZA (1) ZA936137B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP223198A0 (en) * 1998-03-06 1998-04-02 Fujisawa Pharmaceutical Co., Ltd. New use
GB9917158D0 (en) * 1999-07-21 1999-09-22 Fujisawa Pharmaceutical Co New use
ES2343124T3 (es) 1999-10-29 2010-07-23 Novartis Ag Composiciones de polvo seco con dispersabilidad mejorada.
US6878751B1 (en) * 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
AR035411A1 (es) * 2000-12-29 2004-05-26 Fujisawa Pharmaceutical Co Uso de un derivado de tacrolimus para fabricar un agente neurotrofico, composiciones y articulos de fabricacion o kits que lo comprenden, metodo para fabricar un agente que lo comprende y tejidos e injertos con una celula nerviosa tratada con este compuesto
CA2554045A1 (fr) * 2004-01-20 2005-07-28 Astellas Pharma Inc. Methode de traitement des troubles de l'erection
KR20190075120A (ko) 2016-11-10 2019-06-28 노파르티스 아게 Bmp 강화제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323042A1 (fr) * 1987-12-09 1989-07-05 FISONS plc Procédé pour macrolides
IE64214B1 (en) * 1989-06-06 1995-07-26 Fujisawa Pharmaceutical Co Macrolides for the treatment of reversible obstructive airways diseases
GR1001225B (el) * 1989-09-14 1993-06-30 Fisons Plc Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους.
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds

Also Published As

Publication number Publication date
WO1994004148A1 (fr) 1994-03-03
ZA936137B (en) 1994-02-21
AU4967193A (en) 1994-03-15
MX9305152A (es) 1994-05-31
GB9218027D0 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
EP0707446A4 (fr) Compositions pharmaceutiques et leur utilisation pour le traitement d'affections neurologiques et de symptomologies a etiologies associees
IL90910A0 (en) Pharmaceutical composition for the prevention of sexually transmittable diseases
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
HU9402709D0 (en) Pentofixillin for producing pharmaceutical compositions for treating lung diseases of granuloma and fibrozis
IL101245A0 (en) Pharmaceutical compositions for the treatment of prostatic cancer
IL106751A0 (en) Pharmaceutical compositions for the treatment of reversible obstructive airways diseases
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
HUP9900309A3 (en) Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases
IL104132A0 (en) Compositions for the treatment of mammalian diseases
HU9302906D0 (en) Pharmaceutical product for disease of respiratory organs
IL105061A (en) Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof
ZA943342B (en) The use of compositions for combating tumour diseases
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
HUP9801925A3 (en) Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
IL99236A0 (en) Pharmaceutical composition for the topical treatment of psoriasis
HUP9702408A3 (en) Use of 5-phenyloxazolidin-2-one derivatives for the preparation of pharmaceutical compositions treating diseases requiring tumour necrosis factor (tnf) inhibition